text
stringlengths 3
799
|
---|
" D |
3121 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CCCC(CCC)C(=O)O |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: The risk of venous thromboembolism with oral contraceptives such as this molecule exists but remains lower than the risk of this condition during pregnancy and during the postpartum period. |
Option B: It can cross the placental barrier during pregnancy, which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. |
Option C: It is generally considered a lower-risk opioid option for the treatment of moderate to severe pain due to its good tolerability profile and multimodal mechanism of action. |
Option D: Rarely, serious complications may occur in some patients, including hemorrhagic pancreatitis, coagulopathies, bone marrow suppression, VPA-induced hepatotoxicity and encephalopathy. |
" D |
887 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CO |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It is associated with major risks in pregnancy and is therefore only available under the iPLEDGE program in the United States. |
Option B: It is rarely used as an insecticide due to the risk of poisoning to humans and other animals. |
Option C: It may result in an explosion if large quantities are involved in a fire or if the combustible material is finely divided. |
Option D: Any accumulation of vapors in confined spaces may explode if ignited. |
" D |
784 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: OO |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It is associated with major risks in pregnancy and is therefore only available under the iPLEDGE program in the United States. |
Option B: The risk appears to be highest in patients with current or past substance use disorders. |
Option C: It can cause spontaneous combustion when it comes in contact with organic material. |
Option D: It is rarely used as an insecticide due to the risk of poisoning to humans and other animals. |
" C |
5505 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It is associated with major risks in pregnancy and is therefore only available under the iPLEDGE program in the United States. |
Option B: The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. |
Option C: It has been withdrawn from the market in Europe and the United States due to the risk of cardiac arrhythmias and overdose, possibly leading to death. |
Option D: It has the capability or risk for eliciting hepatotoxicity in patients. |
" B |
3715 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It is associated with a potential reduction in corneal sensitivity accompanied by an increased risk of superficial punctate keratitis and subjective symptoms of discomfort. |
Option B: It is generally considered a lower-risk opioid option for the treatment of moderate to severe pain due to its good tolerability profile and multimodal mechanism of action. |
Option C: It can cross the placental barrier during pregnancy, which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. |
Option D: The risk of venous thromboembolism with oral contraceptives such as this molecule exists but remains lower than the risk of this condition during pregnancy and during the postpartum period. |
" A |
23668193 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: N(=O)[O-].[Na+] |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It is associated with major risks in pregnancy and is therefore only available under the iPLEDGE program in the United States. |
Option B: It may result in an explosion if large quantities are involved in a fire or if the combustible material is finely divided. |
Option C: Any accumulation of vapors in confined spaces may explode if ignited. |
Option D: It is rarely used as an insecticide due to the risk of poisoning to humans and other animals. |
" B |
5282379 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C\\C(=O)O)/C)/C |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: The harms are generally considered to outweigh the small clinical benefit of use of it due to the risk of adverse effects. |
Option B: It has been withdrawn from the market in Europe and the United States due to the risk of cardiac arrhythmias and overdose, possibly leading to death. |
Option C: It is generally considered a lower-risk opioid option for the treatment of moderate to severe pain due to its good tolerability profile and multimodal mechanism of action. |
Option D: It is associated with major risks in pregnancy and is therefore only available under the iPLEDGE program in the United States. |
" D |
6432 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: C(C(F)(F)F)(C(F)(F)F)(F)F |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It has been withdrawn from the market in Europe and the United States due to the risk of cardiac arrhythmias and overdose, possibly leading to death. |
Option B: Asphyxiation may occur because of displacement of oxygen, although the mixture is nonflammable and nontoxic. |
Option C: It is generally considered a lower-risk opioid option for the treatment of moderate to severe pain due to its good tolerability profile and multimodal mechanism of action. |
Option D: The harms are generally considered to outweigh the small clinical benefit of use of it due to the risk of adverse effects. |
" B |
33741 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CN(C)C[C@H]1CCCC[C@@]1(C2=CC(=CC=C2)OC)O |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: The risk of venous thromboembolism with oral contraceptives such as this molecule exists but remains lower than the risk of this condition during pregnancy and during the postpartum period. |
Option B: It is associated with a potential reduction in corneal sensitivity accompanied by an increased risk of superficial punctate keratitis and subjective symptoms of discomfort. |
Option C: It can cross the placental barrier during pregnancy, which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. |
Option D: It is generally considered a lower-risk opioid option for the treatment of moderate to severe pain due to its good tolerability profile and multimodal mechanism of action. |
" D |
7111 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: C1=CC(=CC=C1C2=CC=C(C=C2)N)N |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: Patients treated with lorcaserin may have a higher risk of cancer. |
Option B: Occupational exposure to this molecule results in an increased risk of bladder cancer. |
Option C: Consumers of it were at higher risk for gastric cancer than non-consumers. |
Option D: It has been withdrawn from the market in Europe and the United States due to the risk of cardiac arrhythmias and overdose, possibly leading to death. |
" B |
54678486 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)O |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It is generally considered a lower-risk opioid option for the treatment of moderate to severe pain due to its good tolerability profile and multimodal mechanism of action. |
Option B: It can cross the placental barrier during pregnancy, which can result in fetal bleeding, spontaneous abortion, preterm birth, stillbirth, and neonatal death. |
Option C: The risk of venous thromboembolism with oral contraceptives such as this molecule exists but remains lower than the risk of this condition during pregnancy and during the postpartum period. |
Option D: Rarely, serious complications may occur in some patients, including hemorrhagic pancreatitis, coagulopathies, bone marrow suppression, VPA-induced hepatotoxicity and encephalopathy. |
" B |
47811 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC |
Question about this molecule: What is the right safety concern information about this molecule? |
Option A: It has been withdrawn from the market in Europe and the United States due to the risk of cardiac arrhythmias and overdose, possibly leading to death. |
Option B: The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. |
Option C: It increased the risk of cardiac valvulopathy. |
Option D: It has effects on increased serum potassium levels, and is associated with a risk of producing hyperkalemia. |
" C |
10100 "Please complete the following question answering task: You are given a SMILES of a molecule and a question about it with several options, please analysis the structure of the molecule and choose the right answer for the question from given options. |
Molecule SMILES: CCC(=O)O[C@](CC1=CC=CC=C1)(C2=CC=CC=C2)[C@H](C)CN(C)C |
Question about this molecule: What is the right safety concern information about this molecule? |